Your browser doesn't support javascript.
loading
Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.
Moore, Ellen C; Sun, Lillian; Clavijo, Paul E; Friedman, Jay; Harford, Joe B; Saleh, Anthony D; Van Waes, Carter; Chang, Esther H; Allen, Clint T.
Afiliação
  • Moore EC; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Sun L; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Clavijo PE; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Friedman J; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Harford JB; SynerGene Therapeutics, Potomac, MD, USA.
  • Saleh AD; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Van Waes C; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, USA.
  • Chang EH; SynerGene Therapeutics, Potomac, MD, USA.
  • Allen CT; Georgetown University Medical Center, Washington, DC, USA.
Oncoimmunology ; 7(7): e1404216, 2018.
Article em En | MEDLINE | ID: mdl-29900037
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos